Work

Immune response with sipuleucel-T in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Phase II ProACT study.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.6_suppl.148

Authors: Thomas A. Gardner, Daniel Peter Petrylak, John M. Corman, Simon Hall, Ralph Weinstein, Robert Keyser, Robert Brownell Sims, Amanda Sanders, Nadeem A. Sheikh, Celestia S. Higano

Institutions: Indiana University Indianapolis, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Columbia University Irving Medical Center, Virginia Mason Medical Center, Icahn School of Medicine at Mount Sinai, Dendreon (United States), University of Washington

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W91773918

Cites:

Cited by: 1

Related to: 10